openPR Logo
Press release

What's driving the Drug Integrated Polymer Fibers Market trends? Key Company Profiled in TissueGen Inc., Micro Engineering Solutions

Drug Integrated Polymer Fibers Market

Drug Integrated Polymer Fibers Market

According to a new research report by Global Market Insights, Inc. Drug Integrated Polymer Fibers Market size will exceed USD 88.8 million by 2025. Rising population, improved healthcare facilities in developing economies, growing implantable medical surgeries, technological advancement in medical textile engineering along with rise in R&D activities to replace traditional materials with innovative biomaterials will primarily drive the drug integrated polymer fibers market till 2025.

At present, only TissueGen Inc, and Micro Engineering Solutions are the two main players in this business. However, a large number of companies are expected to enter this business due to unknown hidden potential of these fibers in drug delivery.

Request for a sample copy of this report @

Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid) and other copolymers. These fibers also called as pharmaceutical fibers and can be loaded with variety of drugs. These fibers are generally available in woven, knitted or braided form for a medical textile device. These fibers find wide applications in orthopaedics, drug delivery, vascular grafts and stents along with dermal healing. Although the market for drug integrated polymer fibers is very small at the moment, it is expected to rise significantly during the forecast period because of rise in innovative materials globally for orthopaedics, rise in old age population especially in European & North American continent.

Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers. Textiles are being considered as logical choice for soft tissue repair including hernias, ligaments and tendons due to its fibrous nature of human body.

- Drug integrated polymer fibers market by type

o Polylactic acid
o Polydioxanone
o Polycaprolactone
o Others (PGA, PLGA, PDLL)

- Drug integrated polymer fibers market by application

• Drug delivery
• Orthopaedic sutures
• Vascular stents
• Vascular grafts
• Dermal wound healing

Browse Complete Report Summary @

Drug integrated polymer fibers have been typically manufactured through melt extrusion at high shear and high temperatures- conditions that have severe limitations on pharmaceuticals and biologics. To address these concerns, a wet extrusion method has been developed for manufacturing drug loaded fibers, which occurs at lower temperature and has low shear stress. In wet extrusion process, a solution of polymers is put to pressure and is injected in a coagulating bath comprised of solution that is miscible with solvent which dissolves the solvent.

Progress in topical fiber-based biologics and pharmaceuticals along with breakthrough in regenerative medicine and tissue engineering and is paving the next generation orthopedic medical products market. Controlled pharmaceutical delivery through biodegradable fibers has the potential to revolutionize many applications including orthopaedics.

Usage of traditional surgical methods in developing nations along with high cost of drug integrated polymer fibers are some of the factor that can restraint the market from its full growth.

Make an inquiry for purchasing this report @

Drug integrated polymer fibers are being widely used in variety of biomedical applications as it exhibits both biocompatibility and biodegradability properties both highly important for medical textile applications. Biodegradable polymers such as PLA, PLLA, PGA, PCL involves cost effective production and can be up scaled easily with less complicated machinery. Also, the mechanical properties along with the degradation kinetics of these polymers can be tailored to match the requirements of intended applications by controlling curing temperature, curing time. Because of the flexible and fibrous nature of these polymers its medical textile applications have mainly targeted soft tissue replacement and the engineering of soft tissues, such as cardiac muscle, blood, nerve, cartilage and retina.

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Contact Person: Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Drug Integrated Polymer Fibers Market trends? Key Company Profiled in TissueGen Inc., Micro Engineering Solutions here

News-ID: 1615669 • Views: 389

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning